Resultados de la búsqueda 381-390 of 22931 for cancer
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study). Rochester, Minn. This is an international phase III trial, with a ...
Alianza de Minnesota contra el Cáncer. Los miembros del personal del Centro Oncológico Integral de Mayo Clinic (Mayo Clinic Comprehensive Cancer Center) han ...
... cancer (from blood and tissue samples) to improve the overall accuracy ... cancer therapy and compare it to the biopsy performed prior to cancer treatment.
... cancer; to determine the safety and toxicity of on-time and serial administration of MV-s-NAP in patients with metastic breast cancer. Natural History ...
... cancer, and to evaluate whether the baseline peripheral blood immune phenotype differs between patients with breast cancer and age-matched healthy controls.
Lymphoma is cancer that affects the lymphatic system. The lymphatic system is made up of organs, glands, tubelike vessels and clusters of cells called lymph ...
El cáncer de mama HER2-positivo es un tipo de cáncer que da un resultado ... Un libro: Beyond Breast Cancer (Más allá del cáncer de mama) · Dona hoy para ...
Cancers. PET scans are used to diagnose many cancers, including prostate cancer, breast cancer, pancreatic cancer, skin cancer, bladder cancer, kidney cancer ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?